NadolJBJr,. Histopathology of pseudomonas osteomyelitis of the temporal bone starting as malignant external otitis. Am J Otolaryngol1980;1:35971.
5.
CunninghamM, YuV, TurnerJ. Necrotizing otitis externa due to Aspergillus in an immunocompromised patient. Arch Otolaryngol Head Neck Surg1988;114:5546.
6.
StanleyR, McCaffreyTV, WeilandL. Fungal mastoiditis in the immunocompromised host. Arch Otolaryngol Head Neck Surg1988;114:1989.
7.
PetrakR, PottageJ, LevinS. Invasive external otitis caused by Aspergillus fumigatus in an immunocompromised patient. J Infect Dis1985;151:196.
8.
BickleyL, BettsR, ParkinsC. Atypical invasive external otitis from Aspergillus. Arch Otolaryngol Head Neck Surg1988;114:10248.
SchaffnerA, DouglasH, BraudeA. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest1982;69:61731.
11.
DiamondRD. Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones. J Infect Dis1983:147:160.
12.
ChandlerJR. Pathogenesis and treatment of facial paralysis due to malignant external otitis. Ann Otol Rhinol Larynbol1972;81:64858.
13.
FaduluS. Experimental Aspergillosis: role of endotoxin in pathogenesis and neurologic manifestations of Aspergillosis. In: IwataK, ed. Recent advances in medical and veterinary mycology.Baltimore: University Park Press, 1975: 17788.
14.
GartyI, RosenG, HoldsteinY. The radionuclide diagnosis, evaluation, and follow-up of malignant otitis media (MEO). J Laryngol Otol1985;99:10915.